Positron emission tomography: a new method for determination of renal function

Area of Science:

• Nephrology
• Nuclear Medicine
• Physiology

Background:

• Positron emission tomography (PET) is an evolving diagnostic tool with broad clinical applications.
• Its utility in assessing kidney disorders and renal blood flow (RBF) has not been previously established.
• Accurate RBF measurement is crucial for diagnosing and managing various renal pathologies.

Purpose of the Study:

• To evaluate the safety, efficiency, and accuracy of PET using N-13 ammonia for measuring RBF in a swine model.
• To determine PET's ability to detect changes in RBF under various physiological and pathological conditions.
• To establish PET as a quantitative tool for assessing renal function.

Main Methods:

• Utilized N-13 ammonia as a radiotracer for flow-dependent extraction measurements.
• Administered intravenous injections to swine (N=10) to quantify RBF.
• Studied RBF changes in response to warm ischemia, allograft rejection, unilateral nephrectomy, and cyclosporine toxicity.

Main Results:

• Established a mean baseline RBF of 3.16 ml/min/gm, consistent with invasive methods.
• Demonstrated progressive RBF decrease with increasing warm ischemia duration.
• Observed significant RBF reduction in acute allograft rejection and an inverse relationship with cyclosporine levels.
• Documented a two-fold increase in RBF in the remaining kidney after unilateral nephrectomy, indicating compensatory hypertrophy.

Conclusions:

• Positron emission tomography (PET) provides a safe, efficient, and accurate method for quantifying renal blood flow (RBF).
• PET can detect and assess changes in RBF across diverse physiological states, including ischemia, rejection, compensatory hypertrophy, and drug toxicity.
• The application of PET for quantitative renal function assessment holds significant promise for clinical nephrology.